PULMATRIX, INC. Repayments of Related Party Debt
PULMATRIX, INC. (PULM) reported Repayments of Related Party Debt of $537.00 thousand for the 12-month period ending 2015-03-31, per its 10-K filed 2015-06-10.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfRelatedPartyDebt · last filed 2015-06-10
- PULMATRIX, INC. repayments of related party debt for the quarter ending 2015-03-31 was $1.00K, a 99.89% decline year-over-year.
- PULMATRIX, INC. repayments of related party debt for the quarter ending 2014-12-31 was $1.00K.
- PULMATRIX, INC. repayments of related party debt for the quarter ending 2014-09-30 was $5.00K.
- PULMATRIX, INC. repayments of related party debt for the quarter ending 2014-06-30 was $530.00K.
- PULMATRIX, INC. repayments of related party debt for fiscal 2015 was $537.00K, a 41.38% decline from fiscal 2014.
- PULMATRIX, INC. repayments of related party debt for fiscal 2014 was $916.00K.
| Period end | Repayments of Related Party Debt 3 month | Repayments of Related Party Debt 6 month | Repayments of Related Party Debt 9 month | Repayments of Related Party Debt 12 month |
|---|---|---|---|---|
| 2015-03-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-06-10 | $2.00K derived: sum of 2 quarters · filed 2015-06-10 | $7.00K derived: sum of 3 quarters · filed 2015-06-10 | $537.00K 10-K · filed 2015-06-10 |
| 2014-12-31 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-02-13 | $6.00K derived: sum of 2 quarters · filed 2015-02-13 | $536.00K 10-Q · filed 2015-02-13 | $1.45M derived: sum of 4 quarters · filed 2015-06-10 |
| 2014-09-30 | $5.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-11-13 | $535.00K 10-Q · filed 2014-11-13 | $1.45M derived: sum of 3 quarters · filed 2015-06-10 | $1.45M derived: sum of 4 quarters · filed 2015-06-10 |
| 2014-06-30 | $530.00K 10-Q · filed 2014-08-14 | $1.45M derived: sum of 2 quarters · filed 2015-06-10 | $1.45M derived: sum of 3 quarters · filed 2015-06-10 | $1.45M derived: sum of 4 quarters · filed 2015-06-10 |
| 2014-03-31 | $916.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-06-10 | $916.00K derived: sum of 2 quarters · filed 2015-06-10 | $916.00K derived: sum of 3 quarters · filed 2015-06-10 | $916.00K 10-K · filed 2015-06-10 |
| 2013-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-02-13 | $0.00 derived: sum of 2 quarters · filed 2015-02-13 | $0.00 10-Q · filed 2015-02-13 | |
| 2013-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-11-13 | $0.00 10-Q · filed 2014-11-13 | ||
| 2013-06-30 | $0.00 10-Q · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |